Impact of the main forms of treatment on the quality of life of patients with breast cancer

Authors

DOI:

https://doi.org/10.33448/rsd-v11i8.30450

Keywords:

Breast cancer; Treatments; Quality of life.

Abstract

Breast cancer is the form that most affects women worldwide, both in developed and developing countries. About 2.3 million new cases were estimated for the year 2020 worldwide, representing approximately 25% of all types of neoplasms diagnosed in women. Incidence rates vary between different regions of the planet, with the highest rates in developed countries. For Brazil, 66,280 new cases of breast cancer were estimated in 2021, with an estimated risk of 61.61 cases per 100,000 women. This study aimed to prepare an updated review of the main methods of treating breast cancer and its consequences on the quality of life of patients. This research is a bibliographic review of the narrative type developed through the search for publications in the databases: Medline, SciELO and Science direct in order to enrich the specialized literature on the importance of dealing with this issue in society. The descriptors were used: breast cancer, treatment, quality of life, chemotherapy, radiotherapy, surgery and immunotherapy. Through the survey carried out in this study, we were able to verify that most treatments are invasive and directly interfere in the socioeconomic aspects and also in the quality of life of the woman. It is concluded that early treatment and reception by the family are of enormous importance for a better quality of life for women during this period, and also the need to carry out further studies on new forms of treatment with less effect on women's quality of life.

References

Al-Hilli, Z., & Boughey, J. C. (2016). The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer. Chinese clinical oncology, 5(3), 37. https://doi.org/10.21037/cco.2016.03.26

Almeida, T. R. de, Guerra, M. R., & Filgueiras, M. S. T. (2012). Repercussões do câncer de mama na imagem corporal da mulher: uma revisão sistemática. Physis (Rio de Janeiro, Brazil), 22(3), 1003–1029. https://doi.org/10.1590/s0103-73312012000300009

Almuwaqqat, Z., Meisel, J. L., Barac, A., & Parashar, S. (2019). Breast Cancer and Heart Failure. Heart failure clinics, 15(1), 65–75. https://doi.org/10.1016/j.hfc.2018.08.007

Bahia, J. C., Lima, C. M., Oliveira, M. M. de, Guimarães, J. V., Santos, M. de O., & Mota, D. D. C. de F. (2019). Fadiga em Mulheres com Câncer de Mama Submetidas à Radioterapia. Revista Brasileira De Cancerologia, 65(2), e–09089. https://doi.org/10.32635/2176-9745.RBC.2019v65n2.89

Barginear, M. F., Bradley, T., Shapira, I., & Budman, D. R. (2008). Implications of applied research for prognosis and therapy of breast cancer. Critical Reviews in Oncology/Hematology, 65(3), 223–234. https://doi.org/10.1016/j.critrevonc.2007.11.004

Bernardes, N., Sá, A., Facioli, L., Ferreira, M., Sá, O., & Costa, R. (2019). Câncer de Mama X Diagnóstico / Breast Cancer X Diagnosis. ID on line. Revista de psicologia, 13(44), 877-885. doi:https://doi.org/10.14295/idonline.v13i44.1636

Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D., Feuer, E. J., & Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. The New England journal of medicine, 353(17), 1784–1792. https://doi.org/10.1056/NEJMoa050518.

Bezerra, T. S., Rett, M. T., Mendonça, A. C. R., Santos, D. E. dos, Prado, V. M., & DeSantana, J. M. (2012). Hipoestesia, dor e incapacidade no membro superior após radioterapia adjuvante no tratamento para câncer de mama. Revista Dor, 13(4), 320–326. https://doi.org/10.1590/s1806-00132012000400003

Borghaei, H., Smith, M. R., & Campbell, K. S. (2009). Immunotherapy of cancer. European journal of pharmacology, 625(1-3), 41–54. https://doi.org/10.1016/j.ejphar.2009.09.067

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492

Brito, C., Portela, M. C., & Vasconcellos, M. T. L. de. (2014). Revista de Saude Publica, 48(2), 284–295. https://doi.org/10.1590/s0034-8910.2014048004799

Burstein, H. J., Temin, S., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Rowden, D., Solky, A. J., Stearns, V., Winer, E. P., & Griggs, J. J. (2014). Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 32(21), 2255–2269. https://doi.org/10.1200/JCO.2013.54.2258

Cardoso, F., Harbeck, N., Fallowfield, L., Kyriakides, S., Senkus, E., & ESMO Guidelines Working Group (2012). Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology: official journal of the European Society for Medical Oncology, 23 Suppl 7, vii11–vii19. https://doi.org/10.1093/annonc/mds232

Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008). Medication compliance and persistence: terminology and definitions. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research, 11(1), 44–47. https://doi.org/10.1111/j.1524-4733.2007.00213.x

Ferreira, E. B. (2019). Intervenções tópicas para prevenção da radiodermatite aguda em pacientes com câncer de cabeça e pescoço: revisão sistemática e metanálise. Biblioteca Central da UNB.

Ferreira, R. G., & Franco, L. F. R (2017). Efeitos colaterais decorrentes do tratamento quimioterápico no câncer de mama: revisão bibliográfica. Revista da Universidade Vale do Rio Verde, Três Corações, 15(2), 633-638. http://dx.doi.org/10.5892/ruvrd.v15i2.3759.g3297

Freire, D. (2019). Imunoterapia: a virada do sistema imunológico contra o câncer. Ciencia e cultura, 71(4), 13–15. https://doi.org/10.21800/2317-66602019000400006

Gieni, M., Avram, R., Dickson, L., Farrokhyar, F., Lovrics, P., Faidi, S., & Sne, N. (2012). Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: a meta-analysis. Breast (Edinburgh, Scotland), 21(3), 230–236. https://doi.org/10.1016/j.breast.2011.12.013

Haddad, C. F. (2010). Trastuzumab no câncer de mama. Femina. 38(2):73-77. http://files.bvs.br/upload/S/0100-7254/2010/v38n2/a001.pdf

Atlas On-line de Mortalidade. ([s.d.]). Gov.br. Recuperado 17 de maio de 2022, de https://www.inca.gov.br/app/mortalidade

Estimativa 2020: incidência de câncer no Brasil. (2019, dezembro 9). INCA - Instituto Nacional de Câncer. https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil

International Agency for Research on Cancer (IARC). cancer today. Iarc.fr website: https://gco.iarc.fr/today/home

INSTITUTO NACIONAL DE CÂNCE, INCA. O que é câncer?

INSTITUTO NACIONAL DE CÂNCE, INCA. Tratamento. <https://www.inca.gov.br/controle-do-cancer-de-mama/acoes-de-controle/tratamento>.

Järvenpää, R., Holli, K., Pitkänen, M., Hyödynmaa, S., Rajala, J., Lahtela, S. L., & Ojala, A. (2006). Radiological pulmonary findings after breast cancer irradiation: A prospective study. Acta oncologica (Stockholm, Sweden), 45(1), 16–22. https://doi.org/10.1080/02841860500334921

Falçoni Júnior, A. T., Savazzini-Reis, B., Zorzanelli, B. A. de C., Sadovsky, C. I., & Carletti, E. Z. B. (2020). Imunoterapia. Revista de Medicina, 99(2), 148–155. https://doi.org/10.11606/issn.1679-9836.v99i2p148-155

Kahán, Z., Csenki, M., Varga, Z., Szil, E., Cserháti, A., Balogh, A., Gyulai, Z., Mándi, Y., Boda, K., & Thurzó, L. (2007). The risk of early and late lung sequelae after conformal radiotherapy in breast cancer patients. International journal of radiation oncology, biology, physics, 68(3), 673–681. https://doi.org/10.1016/j.ijrobp.2006.12.016

Loyola, E. A. C. de, USP, Brazil, Borges, M. L., Magalhães, P. A. P. de, Areco, F. de S., Yochimochi, L. T. B., Panobianco, M. S., USP, Brazil, USP, Brazil, USP, Brazil, USP, Brazil, & USP, Brazil. (2017). Rehabilitation group: Benefits and barriers in the perspective of women with breast cancer. Texto & contexto enfermagem, 26(1). https://doi.org/10.1590/0104-07072017003250015.

Luz G. R. A., Santos G. R., & Rodrigues J. L. G. (2021). A utilização do trastuzumabe na terapia do câncer de mama. Revista Artigos. Com, 32, e9211. Recuperado de https://acervomais.com.br/index.php/artigos/article/view/9211

Maieski, V. M., & Sarquis, L. M. M. (2007). Mulheres com câncer de mama em quimioterapia e sua influência sobre o trabalho. Cogitare Enfermagem. 12(3): 346-352.

Majewski, J. M., Lopes, A. D. F., Davoglio, T., & Leite, J. C. de C. (2012). Qualidade de vida em mulheres submetidas à mastectomia comparada com aquelas que se submeteram à cirurgia conservadora: uma revisão de literatura. Ciencia & saude coletiva, 17(3), 707–716. https://doi.org/10.1590/s1413-81232012000300017

Mansano-Schlosser, T. C., & Ceolim, M. F. (2012). Qualidade de vida de pacientes com câncer no período de quimioterapia. Texto & contexto enfermagem, 21(3), 600–607. https://doi.org/10.1590/s0104-07072012000300015.

Marmot, M., Independent UK Panel on Breast Cancer Screening, Altman, G., Cameron, D. A., Dewar, J. A., Thompson, S. G., & Wilcox, M. (2012). The benefits and harms of breast cancer screening: an independent review. Lancet (London, England), 380(9855), 1778–1786. https://doi.org/10.1016/S0140-6736(12)61611-0

Nader Marta, G., Abdallah Hanna, S., Martella, E., Fernandes da Silva, J. L., & Andrade Carvalho, H. de. (2011). Câncer de mama estádio inicial e radioterapia: atualização. Revista da Associacao Medica Brasileira (1992), 57(4), 468–474. https://doi.org/10.1590/s0104-42302011000400024

Michelone, A. de P. C., & Santos, V. L. C. G. (2004). Revista latino-americana de enfermagem, 12(6), 875–883. https://doi.org/10.1590/s0104-11692004000600005

Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012). Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast cancer research and treatment, 134(2), 459–478. https://doi.org/10.1007/s10549-012-2114-5

Nascimento, A. S., Mello, E. V. de S. L., Schneider, L. C. L., & Almeida, F. L. A. de. (2019). PRINCIPAIS TRATAMENTOS UTILIZADOS NO COMBATE AO CÂNCER DE MAMA: UMA REVISÃO DE LITERATURA. Arquivos do Museu Dinâmico Interdisciplinar, 23(3), 201–219. https://doi.org/10.4025/arqmudi.v23i3.51538.

Nieto, C., Vega, M. A., & Martín Del Valle, E. M. (2020). Trastuzumab: More than a Guide in HER2-Positive Cancer Nanomedicine. Nanomaterials (Basel, Switzerland), 10(9), 1674. https://doi.org/10.3390/nano10091674

Noonan, K. A., Huff, C. A., Davis, J., Lemas, M. V., Fiorino, S., Bitzan, J., Ferguson, A., Emerling, A., Luznik, L., Matsui, W., Powell, J., Fuchs, E., Rosner, G. L., Epstein, C., Rudraraju, L., Ambinder, R. F., Jones, R. J., Pardoll, D., & Borrello, I. (2015). Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma. Science translational medicine, 7(288), 288ra78. https://doi.org/10.1126/scitranslmed.aaa7014

Oliveira, A. T., & de Almeida Queiroz, A. P. (2012). Profile use of oral antineoplastic therapy: the importance of pharmaceutical guidance. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 3(4). https://rbfhss.org.br/sbrafh/article/view/145.

Paiva, C. J. K. de, & Cesse, E. Â. P. (2015). Aspectos Relacionados ao Atraso no Diagnóstico e Tratamento do Câncer de Mama em uma Unidade Hospitalar de Pernambuco. Revista Brasileira de Cancerologia, 61(1), 23–30. https://doi.org/10.32635/2176-9745.rbc.2015v61n1.374.

Porter P. (2008). "Westernizing" women's risks? Breast cancer in lower-income countries. The New England journal of medicine, 358(3), 213–216. https://doi.org/10.1056/NEJMp0708307

Pereira, A. P. V., Molina, M. A., Furtado, L. F. T., de Ferreira Santos, G. R., & De Faria Nogueira Luz, T. (2019). Mastectomia e mamoplastia na vida das mulheres com câncer de mama. Cadernos da Medicina - UNIFESO, 2(1). https://www.unifeso.edu.br/revista/index.php/cadernosdemedicinaunifeso/article/view/1294/57.

Pereira, S. G., Rosenhein, D. P., Bulhosa, M. S., Lunardi, V. L., & Lunardi Filho, W. D. (2006). Vivências de cuidados da mulher mastectomizada: uma pesquisa bibliográfica. Revista brasileira de enfermagem, 59(6), 791–795. https://doi.org/10.1590/s0034-71672006000600013.

Pinto, A. C., Ades, F., de Azambuja, E., & Piccart-Gebhart, M. (2013). Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies. Breast (Edinburgh, Scotland), 22 Suppl 2, S152–S155. https://doi.org/10.1016/j.breast.2013.07.029

Pisoni, A. C., Kolankiewicz, A. C. B., Scarton, J., Loro, M. M., Souza, M. M. de, & Rosanelli, C. de L. S. P. (2013). Dificuldades vivenciadas por mulheres em tratamento para o câncer de mama. Revista de Pesquisa (Univ. Fed. Estado Rio J., Online), 194–201. https://pesquisa.bvsalud.org/portal/resource/pt/lil-683559.

Rapoport, B. L., Demetriou, G. S., Moodley, S. D., & Benn, C. A. (2014). When and how do I use neoadjuvant chemotherapy for breast cancer?. Current treatment options in oncology, 15(1), 86–98. https://doi.org/10.1007/s11864-013-0266-0

Richards, M. A., Westcombe, A. M., Love, S. B., Littlejohns, P., & Ramirez, A. J. (1999). Influence of delay on survival in patients with breast cancer: a systematic review. Lancet (London, England), 353(9159), 1119–1126. https://doi.org/10.1016/s0140-6736(99)02143-1

Richie, R. C., & Swanson, J. O. (2003). Breast cancer: a review of the literature. Journal of insurance medicine (New York, N.Y.), 35(2), 85–101.

Rolnick, S. J., Pawloski, P. A., Hedblom, B. D., Asche, S. E., & Bruzek, R. J. (2013). Patient characteristics associated with medication adherence. Clinical medicine & research, 11(2), 54–65. https://doi.org/10.3121/cmr.2013.1113

Rother, E. T. (2007). Revisão sistemática X revisão narrativa. Acta Paulista de Enfermagem, 20:v-vi.

Sanchez, K. de O. L., Ferreira, N. M. L. A., Dupas, G., & Costa, D. B. (2010). Revista brasileira de enfermagem, 63(2), 290–299. https://doi.org/10.1590/s0034-71672010000200019

Sawada, N. O., Nicolussi, A. C., Okino, L., Cardozo, F. M. C., & Zago, M. M. F. (2009). Avaliação da qualidade de vida de pacientes com câncer submetidos à quimioterapia. Revista da Escola de Enfermagem da U S P, 43(3), 581–587. https://doi.org/10.1590/s0080-62342009000300012

Schneider, F., Pedrolo, E., Lind, J., Schwanke, A. A., & Danski, M. T. R. (2013). Prevenção e tratamento de radiodermatite: uma revisão integrativa. Cogitare Enfermagem, 18(3). https://doi.org/10.5380/ce.v18i3.33575

Seité, S., Bensadoun, R. J., & Mazer, J. M. (2017). Prevention and treatment of acute and chronic radiodermatitis. Breast cancer (Dove Medical Press), 9, 551–557. https://doi.org/10.2147/BCTT.S149752

Silva, C. B., Albuquerque, V., & Leite, J. (2010). Qualidade de Vida em Pacientes Portadoras de Neoplasia Mamária Submetidas a Tratamentos Quimioterápicos. Revista Brasileira de Cancerologia, 56(2), 227–236. https://doi.org/10.32635/2176-9745.rbc.2010v56n2.1501

Brito-Silva, K., Bezerra, A. F. B., Chaves, L. D. P., & Tanaka, O. Y. (2014). Integralidade no cuidado ao câncer do colo do útero: avaliação do acesso. Revista de saude publica, 48(2), 240–248. https://doi.org/10.1590/s0034-8910.2014048004852

TCU ([s.d.]). Auditoria Operacional na Política Nacional de Atenção Oncológica. Gov.br. https://portal.tcu.gov.br/biblioteca-digital/auditoria-operacional-na-politica-nacional-de-atencao-oncologica.htm

Tfayli, A., Temraz, S., Abou Mrad, R., & Shamseddine, A. (2010). Breast cancer in low- and middle-income countries: an emerging and challenging epidemic. Journal of oncology, 2010, 490631. https://doi.org/10.1155/2010/490631

Thuler, L. C. S., & Mendonça, G. A. (2005). Estadiamento inicial dos casos de câncer de mama e colo do útero em mulheres brasileiras. Revista brasileira de ginecologia e obstetricia: revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 27(11), 656–660. https://doi.org/10.1590/s0100-72032005001100004.

Tiezzi, D. G. (2007). Cirurgia conservadora no câncer de mama. Revista brasileira de ginecologia e obstetricia: revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 29(8), 428–434. https://doi.org/10.1590/S0100-72032007000800008.

Verde, S. M. M. L., São Pedro, B. M. O., Mourão Netto, M., & Damasceno, N. R. T. (2009). Aversão alimentar adquirida e qualidade de vida em mulheres com neoplasia mamária. Revista de Nutrição, 22(6), 795–807. https://doi.org/10.1590/s1415-52732009000600002.

Published

10/06/2022

How to Cite

AGUIAR, R. de C. S. .; FREITAS, E. C. B. F. .; FREITAS, M. T. de S. . Impact of the main forms of treatment on the quality of life of patients with breast cancer. Research, Society and Development, [S. l.], v. 11, n. 8, p. e8011830450, 2022. DOI: 10.33448/rsd-v11i8.30450. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/30450. Acesso em: 14 nov. 2024.

Issue

Section

Health Sciences